
1257044-40-8 | Venetoclax
CAS:1257044-40-8
MF:C45H50ClN7O7S
MW:868.44
EINECS:820-130-9
MDL No.:MFCD23160052
Venetoclax (CAS 1257044-40-8)
Targeted BCL-2 Inhibitor & Active Pharmaceutical Ingredient
Product Overview
Venetoclax, identified by CAS 1257044-40-8, is a high-affinity BH3-mimetic small molecule that selectively targets and inhibits the B-cell lymphoma 2 (BCL-2) protein. By blocking BCL-2 anti-apoptotic mechanisms, it helps restore programmed cell death in target malignant cell populations. Manufactured under strict quality standards, this active ingredient serves advanced research and pharmaceutical development for hematologic oncology applications.
Distinctive Features
- High Selective Binding: Binds specifically to the BH3 domain of BCL-2 to promote targeted apoptotic pathways.
- High Chemical Purity: Synthesized to precise purity parameters, ensuring low degradation products and stable formulation performance.
- Well-Defined Profile: Characterized by rigorous analytical assays to ensure batch-to-batch consistency for API formulation.
- Good Organic Solubility: Demonstrates consistent solubility in standard laboratory organic solvents like DMSO for research and process testing.
Target Applications
Synonyms / Alternative Names
Venetoclax; Venclexta; Venclyxto; ABT-199; ABT 199; 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide; Benzamide, 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-.
Hot Tags: 1257044-40-8 | Venetoclax, China 1257044-40-8 | Venetoclax manufacturers, suppliers, api kerberos integration, Brivaracetam, api caching mechanisms, api financial management api integration, api serverless architecture, api startup api integration

